High expression of ACKR1 predicts a good prognosis and suppresses sarcoma cell progression via regulating the tumor immune microenvironment

Albarran V, Villamayor ML, Chamorro J, Rosero DI, Pozas J, San Roman M, Calvo JC, Perez de Aguado P, Moreno J, Guerrero P, Gonzalez C, Garcia de Quevedo C, Alvarez-Ballesteros P, Vaz MA (2022) Receptor tyrosine kinase inhibitors for the treatment of recurrent and unresectable bone sarcomas. Int J Mol Sci 23(22):13784

Article  CAS  PubMed  PubMed Central  Google Scholar 

Blum A, Wang P, Zenklusen JC (2018) SnapShot: TCGA-analyzed tumors. Cell 173(2):530

Article  CAS  PubMed  Google Scholar 

Caiazza C, Brusco T, D’Alessio F, D’Agostino M, Avagliano A, Arcucci A, Ambrosino C, Fiume G, Mallardo M (2022) The lack of STING impairs the MHC-I dependent antigen presentation and JAK/STAT signaling in murine macrophages. Int J Mol Sci 23(22):14232

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cheng R, Santos HA (2023) Smart Nanoparticle-Based Platforms for Regulating Tumor Microenvironment and Cancer Immunotherapy. Adv Healthc Mater 12(8)

Das S, Faruqi S, Nordal R, Starreveld Y, Kelly J, Bowden G, Amanie J, Fairchild A, Lim G, Loewen S, Rowe L, Wallace C, Ghosh S, Patel S (2022) A phase III, multicenter, randomized controlled trial of preoperative versus postoperative stereotactic radiosurgery for patients with surgically resectable brain metastases. BMC Cancer 22(1):1368

Article  PubMed  PubMed Central  Google Scholar 

Jenkins BD, Martini RN, Hire R, Brown A, Bennett B, Brown I, Howerth EW, Egan M, Hodgson J, Yates C, Kittles R, Chitale D, Ali H, Nathanson D, Nikolinakos P, Newman L, Monteil M, Davis MB (2019) Atypical chemokine receptor 1 (DARC/ACKR1) in breast tumors is associated with survival, circulating chemokines, tumor-infiltrating immune cells, and African ancestry. Cancer Epidemiol Biomarkers Prev 28(4):690–700

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jinna N, Rida P, Su T, Gong Z, Yao S, LaBarge M, Natarajan R, Jovanovic-Talisman T, Ambrosone C, Seewaldt V (2022) The DARC side of inflamm-aging: duffy antigen receptor for chemokines (DARC/ACKR1) as a potential biomarker of aging, immunosenescence, and breast oncogenesis among high-risk subpopulations. Cells 11(23):3818

Article  CAS  PubMed  PubMed Central  Google Scholar 

Karthik N, Lee JJH, Soon JLJ, Chiu HY, Loh AHP, Ong DST, Tam WL, Taneja R (2022) Histone variant H3.3 promotes metastasis in alveolar rhabdomyosarcoma. J Pathol 259(3):342–356

Larrier NA, Kirsch DG, Riedel RF, Levinson H, Eward WC, Brigman BE (2013a) Practical radiation oncology for extremity sarcomas. Surg Oncol Clin N Am 22(3):433–443

Article  PubMed  Google Scholar 

Larrier NA, Kirsch DG, Riedel RF, Levinson H, Eward WC, Brigman BE (2013b) Practical radiation oncology for extremity sarcomas. Surg Oncol Clin N Am 22(3):433–443

Article  PubMed  Google Scholar 

Latini FR, Bastos AU, Arnoni CP, Muniz JG, Person RM, Baleotti W Jr, Barreto JA, Castilho L, Cerutti JM (2013) DARC (Duffy) and BCAM (Lutheran) reduced expression in thyroid cancer. Blood Cells Mol Dis 50(3):161–165

Article  CAS  PubMed  Google Scholar 

Lee JS, Frevert CW, Wurfel MM, Peiper SC, Wong VA, Ballman KK, Ruzinski JT, Rhim JS, Martin TR, Goodman RB (2003) Duffy antigen facilitates movement of chemokine across the endothelium in vitro and promotes neutrophil transmigration in vitro and in vivo. J Immunol 170(10):5244–5251

Article  CAS  PubMed  Google Scholar 

Li Y, Hu X, Lin R, Zhou G, Zhao L, Zhao D, Zhang Y, Li W, Zhang Y, Ma P, Ren H, Liao X, Niu P, Wang T, Zhang X, Wang W, Gao R, Li Q, Church G et al (2022a) Single-cell landscape reveals active cell subtypes and their interaction in the tumor microenvironment of gastric cancer. Theranostics 12(8):3818–3833

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li Z, Wang M, Tan J, Zhu L, Zeng P, Chen X, Xie L, Duan R, Chen B, Tao T, Wang R, Wang X, Su W (2022b) Single-cell RNA sequencing depicts the local cell landscape in thyroid-associated ophthalmopathy. Cell Rep Med 3(8):100699

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lv M, He F, Guo J, Zheng Z, Wang W, Xie J (2022) Identification of hub genes correlated with tumor-associated M1-like macrophage infiltration in soft tissue sarcomas. Front Genet 13:999966

Article  CAS  PubMed  PubMed Central  Google Scholar 

Maeda S, Kuboki S, Nojima H, Shimizu H, Yoshitomi H, Furukawa K, Miyazaki M, Ohtsuka M (2017) Duffy antigen receptor for chemokines (DARC) expressing in cancer cells inhibits tumor progression by suppressing CXCR2 signaling in human pancreatic ductal adenocarcinoma. Cytokine 95:12–21

Article  CAS  PubMed  Google Scholar 

Nicolo E, Giugliano F, Ascione L, Tarantino P, Corti C, Tolaney SM, Cristofanilli M, Curigliano G (2022) Combining antibody-drug conjugates with immunotherapy in solid tumors: current landscape and future perspectives. Cancer Treat Rev 106:102395

Article  CAS  PubMed  Google Scholar 

Ru B, Wong CN, Tong Y, Zhong JY, Zhong SSW, Wu WC, Chu KC, Wong CY, Lau CY, Chen I, Chan NW, Zhang J (2019) TISIDB: an integrated repository portal for tumor-immune system interactions. Bioinformatics 35(20):4200–4202

Article  CAS  PubMed  Google Scholar 

Rushdi MN, Pan V, Li K, Choi HK, Travaglino S, Hong J, Griffitts F, Agnihotri P, Mariuzza RA, Ke Y, Zhu C (2022) Cooperative binding of T cell receptor and CD4 to peptide-MHC enhances antigen sensitivity. Nat Commun 13(1):7055

Article  CAS  PubMed  PubMed Central  Google Scholar 

Salguero-Aranda C, Olmedo-Pelayo J, de Alava E, Amaral AT, Diaz-Martin J (2022) Genetic alterations and deregulation of hippo pathway as a pathogenetic mechanism in bone and soft tissue sarcoma. Cancers (Basel) 14(24):6211

Article  CAS  PubMed  Google Scholar 

Smith KB, Indelicato DJ, Knapik JA, Lagmay JP, Morris C, Kirwan JM, Zlotecki RA, Scarborough MT, Gibbs CP, Marcus RB (2011) Adjuvant radiotherapy for pediatric and young adult nonrhabdomyosarcoma soft-tissue sarcoma. Int J Radiat Oncol Biol Phys 81(1):150–157

Article  PubMed  Google Scholar 

Sun G, Wang Y, Zhu Y, Huang C, Ji Q (2011) Duffy antigen receptor for chemokines in laryngeal squamous cell carcinoma as a negative regulator. Acta Otolaryngol 131(2):197–203

Article  CAS  PubMed  Google Scholar 

Tang F, Tie Y, Wei YQ, Tu CQ, Wei XW (2021) Targeted and immuno-based therapies in sarcoma: mechanisms and advances in clinical trials. Biochim Biophys Acta Rev Cancer 1876(2):188606

Article  CAS  PubMed  Google Scholar 

Thirasastr P, Brahmi M, Dufresne A, Somaiah N, Blay JY (2022) New drug approvals for sarcoma in the last 5 years. Surg Oncol Clin N Am 31(3):361–380

Article  PubMed  Google Scholar 

Tian Z, Yao W (2023) Chemotherapeutic drugs for soft tissue sarcomas: a review. Front Pharmacol 14:1199292

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tong Y, Pi Y, Cui Y, Jiang L, Gong Y, Zhao D (2022) Early distinction of lymph node metastasis in patients with soft tissue sarcoma and individualized survival prediction using the online available nomograms: a population-based analysis. Front Oncol 12:959804

Article  PubMed  PubMed Central  Google Scholar 

Yang J, Xu Y, Chen Y, Li T, Zhang X, Hu T, Xing R, Yang Y (2022a) Therapeutic perspectives for adult soft tissue sarcoma-updates from the 2022 ASCO annual meeting. Cancer Biol Med 19(10):1496–1502

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang Y, Ye F, Xia T, Wang Q, Du J (2022b) High MICAL1 expression correlates with cancer progression and immune infiltration in renal clear cell carcinoma. BMC Cancer 22(1):1355

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yin Q, Srivastava K, Gebremedhin A, Makuria AT, Flegel WA (2018) Long-range haplotype analysis of the malaria parasite receptor gene ACKR1 in an East-African population. Hum Genome Var 5:26

Article  PubMed  PubMed Central  Google Scholar 

Zhu Q, Jiang L, Wang X (2017) The expression of Duffy antigen receptor for chemokines by epithelial ovarian cancer decreases growth potential. Oncol Lett 13(6):4302–4306

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zou MZ, Liu WL, Chen HS, Bai XF, Gao F, Ye JJ, Cheng H, Zhang XZ (2021) Advances in nanomaterials for treatment of hypoxic tumor. Natl Sci Rev 8(2):nwaa160

Article  CAS  PubMed  Google Scholar 

留言 (0)

沒有登入
gif